Figure 3
From: Pharmacokinetic and metabolomic studies with a BIO 300 Oral Powder formulation in nonhuman primates
A 2D-PCA plot showing time dependent group separation for the lower dose of BIO 300 Oral Powder (100 mg/kg) (A). Volcano plot showing dysregulated metabolites 4 h after BIO 300 Oral Powder administration (B).
